Fluorescence imaging can provide valuable information on the expression,distribution,and activity of drug target proteins.Chemical probes are useful small-molecule tools for fluorescence imaging with high structural f...Fluorescence imaging can provide valuable information on the expression,distribution,and activity of drug target proteins.Chemical probes are useful small-molecule tools for fluorescence imaging with high structural flexibility and biocompatibility.In this review,we briefly introduce two classes of fluorescent probes for the visualization of drug target proteins.Enzymatically activatable probes make use of the specific enzymatic transformations that generally produce a fluorogenic response upon reacting with target enzymes.Alternatively,specific imaging can be conferred with a ligand that drives the probes to target proteins,where the labeling relies on noncovalent binding,covalent inhibition,or traceless labeling by ligand-directed chemistry.展开更多
Medicinal Organometallic Chemistry keeps contributing to drug discovery efforts including the development of diagnostic compounds. Despite the limiting issues of metal-based molecules, e.g., such as toxicity, there ar...Medicinal Organometallic Chemistry keeps contributing to drug discovery efforts including the development of diagnostic compounds. Despite the limiting issues of metal-based molecules, e.g., such as toxicity, there are drugs approved for clinical use and several others are under clinical and pre-clinical development. Indeed, several research groups continue working on organometallic compounds with potential therapeutic applications. For arguably historical reasons, chemoinformatic methods in drug discovery have been applied thus far mostly to organic compounds. Typically, metal-based molecules are excluded from compound data sets for analysis. Indeed, most software and algorithms for drug discovery applications are focused and parametrized for organic molecules. However, considering the emerging field of material informatics, the objective of this Commentary we emphasize the need to develop cheminformatic applications to further develop metallodrugs. For instance, one of the starting points would be developing a compound database of organometallic molecules annotated with biological activity. It is concluded that chemoinformatic methods can boost the research area of Medicinal Organometallic Chemistry.展开更多
在自行研制的质子转移反应质谱(Proton Transfer Reaction Mass Spectrometry,PTR-MS)装置上以丁酮、乙醚等几种常见易制毒化学品为例给出检测结果.发现各自对应唯一的质子化离子峰,谱峰识别简单;分析其他易制毒化学品质子亲和势,说明PT...在自行研制的质子转移反应质谱(Proton Transfer Reaction Mass Spectrometry,PTR-MS)装置上以丁酮、乙醚等几种常见易制毒化学品为例给出检测结果.发现各自对应唯一的质子化离子峰,谱峰识别简单;分析其他易制毒化学品质子亲和势,说明PTR-MS可以对大部分易制毒化学品检测;对浓度为54±3 nmol/L的甲苯标准气体检测结果为51±0.5 nmol/L,绝对量检测准确;通过分析经铂丝催化后的本底信号得到PTR-MS对易制毒化学品的检测限,其中对甲苯检测下限可达5.0×10-2(±50%)nmol/L.结果表明,PTR-MS可选择合适的漂移管约化场E/N,实现对痕量易制毒化学品快速筛选和准确识别.展开更多
基金This work was funded by Japan Science and Technology Agency(JST)ERATO Grant JPMJER1802 and a Grant-in-Aid for Scientific Research on Innovative Areas“Chemistry for Multimolecular Crowding Biosystems”(17H06348).
文摘Fluorescence imaging can provide valuable information on the expression,distribution,and activity of drug target proteins.Chemical probes are useful small-molecule tools for fluorescence imaging with high structural flexibility and biocompatibility.In this review,we briefly introduce two classes of fluorescent probes for the visualization of drug target proteins.Enzymatically activatable probes make use of the specific enzymatic transformations that generally produce a fluorogenic response upon reacting with target enzymes.Alternatively,specific imaging can be conferred with a ligand that drives the probes to target proteins,where the labeling relies on noncovalent binding,covalent inhibition,or traceless labeling by ligand-directed chemistry.
文摘Medicinal Organometallic Chemistry keeps contributing to drug discovery efforts including the development of diagnostic compounds. Despite the limiting issues of metal-based molecules, e.g., such as toxicity, there are drugs approved for clinical use and several others are under clinical and pre-clinical development. Indeed, several research groups continue working on organometallic compounds with potential therapeutic applications. For arguably historical reasons, chemoinformatic methods in drug discovery have been applied thus far mostly to organic compounds. Typically, metal-based molecules are excluded from compound data sets for analysis. Indeed, most software and algorithms for drug discovery applications are focused and parametrized for organic molecules. However, considering the emerging field of material informatics, the objective of this Commentary we emphasize the need to develop cheminformatic applications to further develop metallodrugs. For instance, one of the starting points would be developing a compound database of organometallic molecules annotated with biological activity. It is concluded that chemoinformatic methods can boost the research area of Medicinal Organometallic Chemistry.
文摘在自行研制的质子转移反应质谱(Proton Transfer Reaction Mass Spectrometry,PTR-MS)装置上以丁酮、乙醚等几种常见易制毒化学品为例给出检测结果.发现各自对应唯一的质子化离子峰,谱峰识别简单;分析其他易制毒化学品质子亲和势,说明PTR-MS可以对大部分易制毒化学品检测;对浓度为54±3 nmol/L的甲苯标准气体检测结果为51±0.5 nmol/L,绝对量检测准确;通过分析经铂丝催化后的本底信号得到PTR-MS对易制毒化学品的检测限,其中对甲苯检测下限可达5.0×10-2(±50%)nmol/L.结果表明,PTR-MS可选择合适的漂移管约化场E/N,实现对痕量易制毒化学品快速筛选和准确识别.
